secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hongchang International Co., Ltd (HCIL)
CIK:        0001086303
Form:       8-K
Filed at:   2023-08-23T23:59:59+00:00
Accession:  0001213900-23-070271
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.95
Item codes: 1.01, 3.02, 5.01, 5.02, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heyu Biological to acquire Hongchang BVI in reverse merger; 80.1% control to sellers
--------------------------------------------------------------------------------

- Issues 415,582,375 shares (80.1% of post-close total) to acquire Hongchang BVI, which owns Fujian food industrial park.
- Existing business (HP TECHNOLOGY LIMITED and subsidiaries) sold to director Ban Siong Ang for nominal consideration.
- Board and management overhaul: CEO, CFO, and three directors resign; Zengqiang Lin appointed CEO/President; Wendy Li CFO.
- New directors include Zengqiang Lin, Zhenzhu Lin, Stephan Truly Busch, and Xingjia Gao; Ban Siong Ang remains Chairman.
- Transactions closed August 21, 2023; shares issued under Regulation S exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1086303/000121390023070271/0001213900-23-070271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1086303/000121390023070271/ea184015-8k_heyubio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-070271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer